Medicare Enrolled
Dr. Adam Katz, M.D.
Pulmonary Disease · Tampa, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Katz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Katz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Katz
Dr. Adam Katz is a pulmonary disease specialist in Tampa, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Katz performed 5,107 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Katz received a total of $10,377 from 59 pharmaceutical and/or device companies across 468 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Katz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in FL
$10,377 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 72165 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗5,107
Medicare services
Top 7% in FL for pulmonary disease
Not available
Unique patients (not deduplicated)
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
2,161 | $62 | $106 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,757 | $94 | $180 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
401 | $170 | $350 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
288 | $91 | $180 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
287 | $137 | $299 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
62 | $32 | $80 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
51 | $26 | $85 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
39 | $39 | $85 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
35 | $79 | $160 |
| Exhaled air test for lung function A test that measures exhaled air to evaluate lung function while at rest and during exercise. |
15 | $35 | $88 |
| Emergent tracheostomy An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope. |
11 | $115 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,377
Total received (2018-2024)
Avg $1,482/year across 7 years
Top 20% in FL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
468
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,775
2023
$1,545
2022
$1,341
2021
$974
2020
$748
2019
$1,228
2018
$2,764
Payments by company (2024)
GlaxoSmithKline, LLC.
$257
AstraZeneca Pharmaceuticals LP
$216
GENZYME CORPORATION
$198
Amgen Inc.
$159
HARMONY BIOSCIENCES LLC
$140
Regeneron Healthcare Solutions, Inc.
$127
Insmed, Inc.
$96
Takeda Pharmaceuticals U.S.A., Inc.
$92
Actelion Pharmaceuticals US, Inc.
$82
Mallinckrodt Hospital Products Inc.
$74
Grifols USA, LLC
$66
Electromed, Inc.
$65
Harmony Biosciences Llc
$54
Dompe US, Inc.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Shionogi Inc
$22
Baxter Healthcare
$22
Avadel CNS Pharmaceuticals, LLC
$22
Ambu Inc.
$18
ABIOMED
$13
Top 3 companies account for 37.8% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,610
La Jolla Pharmaceutical Company
$1,375
AstraZeneca Pharmaceuticals LP
$1,214
GENZYME CORPORATION
$507
Amgen Inc.
$503
Boehringer Ingelheim Pharmaceuticals, Inc.
$483
Takeda Pharmaceuticals U.S.A., Inc.
$458
Insmed, Inc.
$341
Regeneron Healthcare Solutions, Inc.
$328
Janssen Pharmaceuticals, Inc
$286
Mylan Specialty L.P.
$266
Novartis Pharmaceuticals Corporation
$246
Electromed, Inc.
$230
Mallinckrodt Hospital Products Inc.
$172
Actelion Pharmaceuticals US, Inc.
$168
HARMONY BIOSCIENCES LLC
$140
Shionogi Inc
$131
Grifols USA, LLC
$130
Astute Medical, Inc.
$116
Cook Medical LLC
$104
Shire North American Group Inc
$94
Philips Electronics North America Corporation
$88
Teva Pharmaceuticals USA, Inc.
$78
Genentech USA, Inc.
$76
United Therapeutics Corporation
$74
JAZZ PHARMACEUTICALS INC.
$74
Abbott Laboratories
$73
Baxter Healthcare
$72
PORTOLA PHARMACEUTICALS, INC.
$71
CSL Behring
$64
UCB, Inc.
$57
Harmony Biosciences Llc
$54
Paratek Pharmaceuticals, Inc.
$52
Merck Sharp & Dohme LLC
$51
Harmony Biosciences LLC
$49
Merck Sharp & Dohme Corporation
$42
Ambu Inc.
$41
Sunovion Pharmaceuticals Inc.
$39
Vapotherm Inc
$36
Alexion Pharmaceuticals, Inc.
$33
Dompe US, Inc.
$29
Inogen, Inc.
$26
Covis Pharma GmBH
$25
PFIZER INC.
$22
Avadel CNS Pharmaceuticals, LLC
$22
Bayer HealthCare Pharmaceuticals Inc.
$21
Gilead Sciences, Inc.
$20
Melinta Therapeutics, Inc.
$20
Circassia Pharmaceuticals Inc
$19
Apellis Pharmaceuticals, Inc.
$19
Pulmonx Corporation
$18
Fisher & Paykel Healthcare Inc
$15
Advanced Respiratory, Inc
$15
Jazz Pharmaceuticals Inc.
$15
Allergan Inc.
$14
ABIOMED
$13
AbbVie Inc.
$12
Allergan, Inc.
$12
Breathe Technologies, Inc.
$12
Top 3 companies account for 40.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AVYCAZ · Adempas · AirDuo Digihaler · Andexxa · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · Briviact · CHARTIS CATHETER · CUVITRU · Cook Medical Zilver PTX · DIFICID · DUPIXENT · Dymista · Esbriet · FASENRA · FISHER & PAYKEL HEALTHCARE · Fetroja · GIAPREZA · GLASSIA · Haegarda · HeartMate · Hillrom - Monarch Airway Clearance System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · Impella · Kcentra · LIFE2000 · LUMRYZ · NIOX VERO · NUCALA · NUZYRA · Nephrocheck · OFEV · OPSUMIT · ORENITRAM · OXERVATE · PREVNAR 20 · Perforomist · Prolastin-C Liquid · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Syfovre · TAVNEOS · TERLIVAZ · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON · Utibron · VAPOTHERM · Vabomere · WAKIX · Wakix · XARELTO · XOLAIR · XYWAV · Xolair · Yupelri · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
101
County median income
$75,011
Nearest hospital to ZIP centroid (approximate)
ST JOSEPHS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Katz is a mixed practice specialist, with above-average Medicare volume (top 7% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Katz experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Katz performed 2,161 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Katz receive payments from pharmaceutical companies?
Yes. Dr. Katz received a total of $10,377 from 59 companies across 468 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Katz's costs compare to other pulmonary diseases in Tampa?
Dr. Katz's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Katz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Tampa
Browse pulmonary diseases in Tampa ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
La Jolla Pharmaceutical Company Payments to Doctors
See all physicians who received payments from La Jolla Pharmaceutical Company.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology